Minocycline 1.5% Foam for the Topical Treatment of Moderate-to-Severe Papulopustular Rosacea: Results of Two Phase 3, Randomized, Clinical Trials.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.01.043
Abstract: BACKGROUND Efficacious topical medications for rosacea are needed. FMX103 1.5% is a novel, topical minocycline foam that may have therapeutic benefits in treating rosacea, while minimizing systemic side effects due to its topical route of… read more here.
Keywords: severe papulopustular; rosacea; treatment; papulopustular rosacea ... See more keywords